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Protocol
AbstrACt
Introduction South Africa is a country known for its 
high levels of HIV infection and sexual violence. Although 
the interface between gender-based violence, HIV and 
mental health has been described, there are substantial 
gaps in knowledge of the medium-term and long-term 
health impact. The 2010 Global Burden of Disease study 
excluded many health outcomes associated with rape and 
other forms of gender-based violence because systematic 
reviews revealed huge gaps in data and poor evidence of 
health effects. This study aims to describe the incidence 
and attributable burden of physical and mental health 
problems (including HIV acquisition) in adult women over 
a 2-year postrape period, through comparison with a 
cohort of women who have not been raped. The study will 
substantially advance our understanding of the impact 
of rape and will generate robust data to assist in the 
development of postrape health services and the delivery 
of evidence-based care.
Methods and analysis This longitudinal study seeks to 
recruit 1008 rape-exposed and 1008 rape non-exposed 
women. Women were recruited from health services, and 
assessments were carried out at baseline, 3, 6, 9, 12, 18 
and 24 months. Outcome measures include exposure to 
risk factors; mental health status; cardio-metabolic risks; 
and biomarkers for HIV, sexually transmitted infections, 
pregnancy and stress. The primary analysis will be to 
compare HIV incidence in the two groups using log-rank 
tests. Appropriate models to predict health outcomes over 
time will also be applied.
Ethics and dissemination The South African Medical 
Research Council’s Ethics Committee approved the study. 
As rape is a key element of the study, the safety and 
protection of participants guides the research process. 
We will adopt a research uptake strategy to ensure 
dissemination to policy makers, service providers and 
advocacy groups. Peer-reviewed journal articles will be 
published.
bACkground
Lifetime exposure to rape and other forms 
of sexual violence is relatively high in most 
countries, as reported in global prevalence 
studies released in June 2013.1 2 Although 
aspects of the health impact of rape have 
been described, the data available have major 
limitations. Systematic reviews to establish 
the magnitude of health effects associated 
with exposure to physical and sexual inti-
mate partner violence (IPV) and non-partner 
sexual violence, including rape, indicate that 
the current evidence is overwhelmingly based 
on cross-sectional studies and/or clinical 
populations.2 Furthermore, the conditions 
studied are mostly limited to mental ill-health 
and aspects of reproductive health. It is thus 
difficult to quantify the health burden in the 
absence of high-quality outcome data from 
longitudinal studies.
The prevention of postrape HIV acqui-
sition has been one of the main targets of 
healthcare following a rape.3 However, the 
pathways to postrape HIV acquisition and 
health outcomes have yet to be fully eluci-
dated. While HIV can be acquired during a 
rape event, rape may indirectly elevate HIV 
acquisition risk in the medium and long term 
through other possible pathways. Evidence 
strengths and limitations of the study
 ► The study will build knowledge in an area with many 
gaps and will contribute to describing the health 
burden of gender-based violence.
 ► The study uses a longitudinal design with a large 
sample and combines biological and behavioural 
data.
 ► The study is conducted in a developing setting.
 ► Recruiting only rape survivors who report rape means 
that our study findings will not be generalisable to all 
rape survivors.
 ► Sexual violence is often under-reported and may 
not be revealed by participants in the non-exposed 
group at screening and enrolment.
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of these pathways stems from research on IPV and HIV.4 
One pathway is via acquiescence, where exposure to IPV 
reduces women’s ability to assert themselves in sexual 
contexts and determine the timing and circumstances of 
sex, including condom use and the insistence on fidelity.5 6 
The second pathway is through elevated high-risk sexual 
behaviour on the women’s part, including engagement 
in sex work, transactional sex, seeking older partners and 
having multiple partners.6–8 The third pathway is that 
while women themselves may not change their behaviour, 
they may sustain or be drawn to relationships with men 
who are at higher risk of being HIV positive than other 
men. There is evidence that men who use violence towards 
women, including rape, are riskier, have more partners, 
have more sexually transmitted infections (STIs) and are 
more likely to be HIV positive. Similarly, men are more 
likely to partner more vulnerable women.9–12
It is likely that these pathways are important postrape 
and that psychological reaction to rape and rape stigma 
are powerful mediators of these pathways. These are, 
in turn, influenced by the circumstances of the rape. 
There is some evidence that self-blame results in 
greater and more enduring psychological impact and 
poorer post-traumatic stress disorder (PTSD) treatment 
responses.13 14 Evidence from rape counselling services 
suggests that court processes after rape may be particularly 
stressful for women,15 but the health impact in general 
has not been empirically described. Research is needed 
to test these pathways described above in relation to rape 
exposure to enable a better understanding of their rela-
tive importance. This is critical for developing tailored 
HIV prevention interventions. Furthermore, there is a 
need for research that combines clinical assessments of 
postrape mental health (ie, PTSD and depression) with 
biological markers of stress. The prolonged release of 
cortisol in the body has been linked to several psychiatric 
disorders, including PTSD,16 and it has been suggested 
that this itself may impact immune system functioning 
and create enhanced susceptibility to HIV infection. 
Further research is needed to investigate links between 
rape, mental ill-health and dysfunctional hypothalamic–
pituitary–adrenal axis activity.17 18
Evolving research is contributing to the better under-
standing of the role of genetics in psychiatric disorders, 
including responses to trauma, such as sexual violence. 
Psychiatric genetics has the potential to inform our 
understanding of neuropsychiatric disorders,19 including 
the development of PTSD and other postrape mental 
health outcomes, and to understand why not all survi-
vors develop mental health disorders.20 21 Factors other 
than the traumatic event are likely to contribute to their 
development. Environmental influences, such as trauma 
(rape), can trigger epigenetic changes resulting in genes 
being silenced or expressed.22 Epigenetic mechanisms 
can therefore be a mediator between genes and the envi-
ronment. Research is needed to deepen our knowledge 
of the role of epigenetics in the development of postrape 
mental health disorders.
The relationship between non-communicable diseases 
(such as cardio-metabolic diseases) and rape has not 
been described in longitudinal studies in the literature. 
Suggestions of a potential relationship can be gained 
from cross-sectional research on the associations between 
physical and psychological IPV and self-reported chronic 
diseases including hypertension, diabetes, asthma, heart 
disease, cancer and arthritis.23 It has been suggested 
that the stress response following rape may lead to the 
development of chronic diseases and its risk factors 
via similar causal pathways as in individuals exposed to 
general psychological stress that are known mediators 
of poor healthcare.24 Direct pathways have been hypoth-
esised via physiological mechanisms when traumatic 
stressors activate a cascade of physiological responses 
that affect the cardiovascular, metabolic, neural, endo-
crine and immune systems.24–26 These include pathways 
via behavioural coping mechanisms such as detrimental 
lifestyle choices. Research is needed to understand these 
associations and the potential pathways using biological 
markers. Many studies, using different study designs and 
approaches, have examined the relationship between 
psychosocial stress and cardiovascular disease (CVD) and 
its risk factors.27–29 None of these studies have described 
the relationship between psychosocial stress triggered by 
rape exposure and the development of CVD risk factors 
in longitudinal studies.
In sub-Saharan Africa, an area with a high population 
prevalence of HIV infection, it is common for women 
who are HIV positive to be raped. Not much is known 
about HIV-positive women who are raped and the specific 
health burden associated with such exposure. In recent 
years, there has been a substantial increase in HIV testing 
across sub-Saharan Africa, especially among women 
attending antenatal services, and a much greater linkage 
to HIV treatment services.30 31 High levels of medication 
adherence and retention during treatment are essential 
for the effectiveness of antiretroviral therapy (ART) in 
preventing HIV disease progression and mortality. Conse-
quently, research on barriers to adherence and retention 
in HIV treatment and care services has been increasing.32 
Psycho-social factors are one group of factors that under-
mine linkage and retention in care, and among rape 
survivors, mental illness and stigma are of particular 
concern because they are recognised barriers to HIV 
adherence and retention in care.33 34 Understanding and 
developing interventions to respond appropriately to the 
impact of rape on women’s ability to adhere to treatment 
and remain in care is important for optimising women’s 
HIV treatment outcomes.
Given the state of the knowledge on the long-term health 
effects of gender-based violence, it is not surprising to find 
few academic papers on recruitment and retention of this 
vulnerable population. Indeed, longitudinal studies are 
challenging to conduct among all study populations. The 
gender-based violence studies that follow participants 
over a period are mainly from clinical settings, in partic-
ular for management of PTSD in populations such as war 
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veterans, or from evaluations of batterers programmes; 
none were found among community samples in devel-
oping settings.35–39
To fill these gaps in the knowledge, we are undertaking 
research that has the overall goal of advancing the under-
standing of the health consequences of rape, notably HIV 
and mental health. This study is particularly well suited to 
being conducted in South Africa because it is a country 
with high sexual violence and HIV incidence9 40 and is the 
country with the largest population of individuals living 
with HIV.41
MEthods/dEsIgn
research aims
The study has one primary aim and eight secondary aims.
Primary aim
To determine the incidence and attributable burden of 
HIV acquisition in adult women up to 24 months postrape 
in comparison to women who have not been raped.
Secondary aims
1. To determine the incidence, attributable burden and 
recovery rates of physical and mental health problems 
that may enhance HIV risk at 3, 6, 9, 12, 18 and 24 
months.
2. To determine the individual, relational, social and 
criminal justice risk factors for health problems at the 
different time points that may be HIV risk factors and 
associated with the persistence of symptoms.
3. To estimate the relative importance of the different 
hypothesised pathways to HIV acquisition.
4. To determine the impact of rape on HIV positive sur-
vivors’ ability to link to HIV care, retention of treat-
ment and sexual risk-taking behaviour.
5. To evaluate changes in cortisol levels and other ste-
roid hormones (cortisone, testosterone, progester-
one, corticosterone and dehydroepiandrosterone) 
over time, measuring their levels in hair, and to evalu-
ate the stress response of women before and after the 
traumatic event of rape.
6. To investigate genetic and epigenetic factors as partic-
ipating biomarkers in the aetiology and trajectory of 
PTSD among rape-exposed women.
7. To determine the incidence and attributable burden 
of CVD risk factors, markers of increased CVD risk 
and hypertension-related and diabetes-related renal 
dysfunction, comparing rape-exposed and non-ex-
posed women.
8. To explore, qualitatively, the experiences of both 
rape-exposed and rape non-exposed women and to 
focus on motivations and experiences of the research 
process, retention issues and the support provided to 
them.
The study is called the Rape Impact Cohort Evalua-
tion (RICE) study and is referred as this throughout this 
paper. This comparative cohort study includes a 24-month 
follow-up. The sample size calculation addresses the 
primary aim. This is based on a log-rank test comparing 
the HIV incidence between rape-exposed and non-ex-
posed groups. To achieve 90% power to detect a signif-
icant difference in HIV incidence, assuming an annual 
incidence of 9% and 6% among the rape-exposed and 
non-exposed groups, respectively, and given an expected 
36-month accrual and a minimum follow-up of 12 months, 
at a 5% significance level and 10% dropout, 193 HIV posi-
tive incident cases will be required.
A minimum HIV negative cohort of 780 participants 
is required in each of the exposure groups. We will 
recruit at least 844 HIV-negative participants in each 
exposure group and the last participant recruited will be 
followed up for 12 months. Research in KwaZulu-Natal 
(KZN), where this study is being undertaken, has found 
an average annual HIV incidence of 10% among young 
women participating in trials.42 We anticipate that 20% of 
participants will be HIV positive at baseline, and as such, a 
total sample size of 2016 (1008 per arm) will be recruited. 
We anticipate a 10% dropout based on previous experi-
ences with cohorts in KZN, where 95%–97% retention 
was achieved in five longitudinal studies.43 All participants 
will have data collected at baseline, 3, 6, 9 and 12 months 
follow-up. Participants recruited earlier in the study will 
also have data collected post 12 months, at 6-month inter-
vals up to 24 months, which will give greater power to the 
study.
setting
The study setting is in and around the city of Durban in 
the KZN province. The rape-exposed participants are 
recruited from four rape services that are spread across 
the city of Durban. Three of the rape centres are Thuthu-
zela Care Centres (TCCs). These are one-stop dedicated 
sexual assault services based at public hospitals providing 
24 hours integrated care to rape survivors, including 
access to police, counselling and medical care, which are 
also described in the law.44 45 The health services provided 
include provision of initial medical and forensic care, 
and HIV prevention is a strong component of the TCC 
model of care. The three TTCs from which we recruit 
our rape-exposed group are based at regional hospitals in 
the north and south of the city (names omitted to ensure 
confidentiality). The fourth recruitment site is the Crisis 
Centre at a regional hospital situated in the city centre. 
The Crisis Centre is not an exclusive sexual assault service 
as the TCCs are but provides similar care to rape survi-
vors. Although more TCCs are located at district hospi-
tals in the rural areas surrounding Durban, it would have 
placed a great financial strain on the study to support 
rural participants. Also, retention is a known challenge, 
as reported in HIV research, if study participants are from 
highly mobile populations, and if the study clinic is situ-
ated some distance from where people live.46 We were 
lucky to set up our research study clinic (RICE clinic) on 
a hospital complex in one of the big southern townships, 
about 20 km south of Durban city centre and within easy 
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access to public transport. We opted to recruit only from 
services within a 50 km radius of the study clinic. However, 
survivors from nearby rural areas may seek services at any 
of the four recruitment sites, and we will recruit these 
people if they indicate their willingness to travel to the 
RICE clinic. Non-rape exposed participants are recruited 
from public health family planning clinics in the same 
vicinity as the recruitment sites of the rape-exposed 
women. Permission to recruit at the TCCs was granted 
by the National Prosecuting Authority (NPA), and the 
Provincial Department of Health granted permission to 
recruit at family planning clinics.
At recruitment, we invite women to our RICE clinic 
where formal informed consent procedures are 
conducted as well as the baseline interview and assess-
ments (see figure 1). We explain in detail the study proce-
dures and the follow-up clinic visits and offer transport 
cost or a transport service to and from the clinic.
Inclusion and exclusion criteria
Rape-exposed participants are women aged 16–40 years 
who have lodged a complaint of rape within the previous 
20 days at a rape centre. Children under 16 years are 
excluded because they constitute a vulnerable group 
that requires additional ethical safeguards. The upper 
age limit of 40 was chosen because the HIV incidence in 
women is much lower over the age of 40 years. The limit 
of 20 days was chosen to ensure that the time points for 
data collection are reasonably standardised across the 
study population and to allow for baseline documenta-
tion of acute stress reactions (PTSD for the current event 
can only be assessed at the follow-up visits) and HIV 
status. Participants are excluded if they are very severely 
mentally distressed, mentally disabled or more than 14 
weeks pregnant.
Participants attending family planning (non-rape 
exposed) are matched for age (+/–1 year) with recruited 
raped-exposed women. The choice of family planning 
clinic clients provides a sexually active control population 
who, like the women seeking services for rape, are also 
engaged with health services. Women who report lifetime 
exposure to sexual violence, as determined by a screening 
questionnaire, are excluded from the non-exposure 
cohort. The same exclusion criteria, as for rape-exposed 
women, such as mentally disabled and more than 14 
weeks pregnant, are also applied. We follow the model of 
recruitment that has been successful in previous studies 
at sexual assault services in South Africa. These include 
a series of information giving and consent processes 
described below and also described in detail elsewhere in 
other publications.47 48
Women recruited in our non-exposed group who report 
a rape and meet the inclusion criteria, that is, enrolled 
Figure 1 Rape Impact Cohort Evaluation study flow chart of participants and samples.
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within 20 days of the rape, will be switched to the exposed 
group.
Assessment of exposure and outcomes measures
Both cohort groups attend the same number of follow-up 
visits and have the same assessments. The interview 
content and outcome measures are listed in table 1. Base-
line interviews are conducted face to face in the language 
that participants are comfortable with (Zulu, English). 
Responses to questions at follow-up interviews are inter-
viewer administered or self-completed, depending on the 
literacy levels of participants and their familiarity with 
computers.
Data are being collected in real time using an electronic 
data management system (see figure 1). Trained staff 
administer the mental health diagnostic assessment, the 
MINI DSM-IV and diagnostic interview face to face.49 The 
research nurse conducts the clinical assessments, collects 
the biological specimens (table 2), conducts HIV testing 
and counselling and administers a pregnancy test and an 
STI test (self-administered vulvar swab for Trichomonas, 
which is treated if positive). We follow the WHO recom-
mendations for HIV rapid testing by conducting a second 
test on all positives as well as an ELISA test (Vironostika 
HIV1/2 Elisa).50 Standard pretest and post-test counsel-
ling is delivered in a culturally sensitive manner. Speci-
mens for herpes simplex virus type 2 (HSV2) testing are 
conducted at 6-month intervals from participants who are 
HSV2 negative at baseline. CD4 count and viral load are 
measured every 6 months, as is the routine in public sector 
clinics, in order to not overly influence health-seeking 
behaviour by observation.
Follow-up interviews and retention
Participants are given a return date and telephonic 
contact is maintained between interviews. The study team 
understands that rape survivors’ lives are often in flux 
in the immediate period after rape, and this can lead to 
considerable mobility and a change in contact details. The 
study retention team (retention counsellor, data manager 
and research assistants responsible for home visits) are 
primarily responsible for problem-solving retention 
barriers. However, all study staff are cognisant that their 
interactions with participants can influence retention. A 
tracking system to monitor retention has been developed 
and is updated daily. This allows for immediate interven-
tion (see discussion below on retention challenges).
data management and analysis
We use a biometric system to identify, track and link partic-
ipants and their different data sources (ie, online inter-
views, clinical data and biological samples) across visits. 
A unique barcoded participating identification (PID) 
number is generated at enrolment, and we use barcodes 
on all samples and documents. Data are collected and 
entered in real time on a dedicated website and moni-
tored daily by the data manager. Data are downloaded to 
a secure server and kept in a password-protected system. 
Laboratory results are merged into the main dataset using 
the unique PID.
The primary analysis is to compare HIV incidence in 
the two groups. The log-rank test will be used to compare 
the groups, taking into account the interval censoring of 
event times that will occur due to the visit schedules. The 
Wilcoxon-type test will be used. To quantify the risk of 
infection, a Cox proportional hazards model will be fitted 
and the HR and 95% CI estimated. Interval censoring will 
also be taken into account in this inference. Mixed-effects 
regression models will be used to model the mental health 
status of participants over time and for the comparison of 
the mean profiles between exposure groups. A random-ef-
fects model for participants will be used to account for the 
clustering effect of the repeated measures. Mixed-effects 
models, restricted to the rape-exposed group, will be used 
to evaluate the association of the individual, relational, 
social and criminal justice factors on mental health, and 
similar analyses will be conducted for different groups of 
interest (ie, the HIV-positive group). We will also examine 
a cascade model depicting the different pathways with the 
cohort of women who are HIV positive and have been 
raped and compare it with HIV-positive women who have 
not been raped. We will handle missing data following the 
guidelines for clinical studies.51 Our primary outcome is 
time to HIV infection. For this analysis, everyone at risk in 
both cohorts will be part of the analysis, and if someone 
leaves the study, the time will be censored. Thus, time-
to-event analysis accommodates missing data in a natural 
way. The one assumption is that the dropout and follow-up 
time will be the same in both groups. For other outcomes, 
that is, mental health status, the repeated measurements 
will include the baseline value and the follow-up values. 
Again, all the information up to the point of leaving the 
study will be included in the analysis. The estimation will 
be conducted using maximum likelihood as described 
above. This is a different approach to accommodating 
missing data than multiple imputation.
It is possible that the two groups are different for 
important variables, which may also impact on risk for 
sexual violence and HIV acquisition. The control of 
confounding variables is therefore critical in our study. 
We collect a wide range of socio-economic variables and 
known confounding variables (see table 1). Furthermore, 
we minimise confounding by choosing a control group 
that also uses health services, and we recruit from health 
services in the same area.
study progrEss And ChAllEngEs
A pilot study to assess the feasibility of recruitment and 
administering the assessment schedule was conducted 
between June and October 2014. We have made a few 
changes to the initial protocol, mainly the change of the 
recruitment window period and the addition of recruit-
ment sites, children and substudies (addition of genetics, 
epigenetics, cardiovascular samples and the qualitative 
component). Recruitment and enrolment commenced 
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Table 1 Exposure and outcome measures at each data collection time point
Variable group Measures Source of measures
A IPV exposure Ever physical, sexual, emotional
Past year, postrape
WHO multi-country study instrument61 (tested in 
South Africa by Jewkes et al)62
B Rape circumstances 
and physical trauma/
injuries
Rape circumstances: number of perpetrators, 
relationship to perpetrator, weapon use, degree 
of violence, type of rape
Intimidation by the perpetrator or friends
Jewkes et al63
(Questions to be asked after criminal case have 
been closed)
C Rape stigma and 
social support
Rape stigma and self-blame
Coping mechanisms
Rape disclosure
Social support
Social disruption: leaving home, school, 
relationship
Social Support Appraisal Scale64; Brief COPE65;
South African Stigma Scale66
D Demographic factors Demographic factors: age, income, education, 
employment, relationship status, sexual 
orientation
Jewkes et al62
E Mental health 
outcomes
Depression
Anxiety disorders
PTSD
Suicidality
Other anxiety disorders
Alcohol and drug abuse
Cortisol level in hair
Epigenetic changes
Telomere length
MINI for psychosis and anxiety disorders49; 
CES-D (depression)67; AUDIT (alcohol)68; DUDIT 
(drugs)68–70; Life Events Checklist71; Davidson 
Trauma Scale (PTSD)72 73
Cortisol in hair and epigenetics analysis from 
blood samples
F Other trauma Previous trauma: child abuse, other interpersonal 
violence or traumatic life events
Follow-up interview: rape, interpersonal violence 
or traumatic life events since the last interview
Childhood trauma scale Bernstein et al74 
modified for South Africa Jewkes et al75
Life Events Checklist; rape and forced sex 
measures from Jewkes et al62
G Criminal justice 
processes and 
circumstances of the 
rape
Case progression: case dropped, arrest, bail, 
guilty plea, case withdrawn, trial commenced, 
testimony in court given, trial outcome
Perceived satisfaction with the system including 
information given about whereabouts of accused
Jewkes et al63; satisfaction questions to be 
developed
(These questions will be asked once criminal 
case have been closed.)
H Acquiescence to 
male domination of 
sex
Attitudes to gender relations and perceived 
social norms
Consistent condom use
Relationship control scale
Sexual frequency
Jewkes et al62; attitudes developed in South 
Africa and validated in Jewkes et al76
I Own sexual risk 
behaviour
Transactional sex
Partner numbers ever and past year
Concurrency
Jewkes et al62  75
J Partner riskiness STIs of current partner
Use of IPV by current partner
Partners’ concurrency/polygamy
Jewkes et al62 4
K Biological risk 
enhancers or co-
factors
Hormonal contraception use at baseline and 
ongoing
Pregnancy loss (since last interview): termination, 
miscarriage
Questions from the Demographic and Health 
Survey77
L Cardio-metabolic 
risk assessment
Screening questions for risk assessment
Measurements: hip and waist, BP, BMI, glucose 
status (glycaemia/Hba1c) and lipid panels
CRP ultrasensitive (cardiac), Gamma-GT, 
ALT (SGPT), AST (SGOT), creatinine (serum),
Questions from the WHO STEPs questionnaire78
Continued
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in November 2014. By April 2017, we had achieved 56.9% 
of the recruitment target for the rape cohort (n=574) 
and a slighter better rate among the non-exposed cohort 
(64.2%; n=647). Our recruitment rate per month among 
the rape-exposed cohort improved from 13 per month 
in 2015 to 23 per month in 2016, and this was mainly 
due to interventions discussed below. We expect this to 
improve marginally and hope to have our full rape cohort 
enrolled by August 2018. The expected end date of the 
study is August 2019 when the 12-month interviews of the 
last participants will be conducted.
recruitment and enrolment challenges
For various reasons, our recruitment was much slower 
than we anticipated in the planning phase. Our initial 
plan was to enrol participants within 5 days of the 
Variable group Measures Source of measures
M Healthcare seeking 
practices postrape 
health, HIV testing 
and adherence
Completion of PEP and STI treatment
Emergency contraception
HIV testing postrape and previously
HIV disclosure
Attendance for health assessment
Commencement of ART and adherence
Experience of HIV-related ill-health
Satisfaction with healthcare provision
Items developed and tested in pilot
O Reproductive and 
child health
Contraception, fertility, pregnancies, reproductive 
health
Child health including babies born during RICE 
study participation
Questions developed and adapted from 
Demographic and Health Survey
ALT, alanine aminotransferase; ART, antiretroviral therapy; AST, aspartate aminotransferase; AUDIT, Alcohol Use Disorders Identification 
Test; BMI, body mass index; BP, blood pressure; CES-D, Center for Epidemiologic Studies Depression Scale; CRP, C-reactive protein; 
DUDIT, Drug Use Disorders Identification Test; IPV, intimate partner violence; MINI, Mini International Neuropsychiatric Interview; PEP, 
postexposure prophylaxis; PTSD, post-traumatic stress disorder; RICE, Rape Impact Cohort Evaluation; SGOT, serum glutamic oxaloacetic 
transaminase; SGPT, serum glutamic pyruvic transaminase; STI, sexually transmitted infection.
Table 1 Continued 
Table 2 Clinical assessments and biological samples at each visit
Baseline 3 months 6 months 9 months 12 months 18 months 24 months
  Biometrics X X X X X X X
  Clinical assessment X X X X X X X
  Mental health assessment X X X X X X X
  HIV and trauma counselling X X X X X X X
Laboratory evaluations
  HIV rapid test and ELISA X X X X X X X
  Pregnancy test X X X X X X X
  Trichomonas swab X X X X X X X
  HSV2 X X X X X X X
  Glucose/lipid panels CRP 
ultrasensitive (cardiac), Gamma-GT, 
ALT (SGPT), AST (SGOT), creatinine
X X X
  Cortisol (hair sample) X X X X X
  Genetic and epigenetic tests X X X X X X X
Virology (HIV positive)
  Viral load and CD4 X X X X
  p-Antigen 24 (sero-converted) X X X X X X X
Storage
  Plasma X X X X X X X
  Serum X X X X X X X
ALT, alanine aminotransferase; AST, aspartate aminotransferase; HSV2, herpes simplex virus type 2; SGOT, serum glutamic oxaloacetic 
transaminase; SGPT, serum glutamic pyruvic transaminase.
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rape event, but we found this to be a huge challenge 
and enrolment was very slow. The window period for 
enrolment was extended to 10 days and later to 20 days 
postrape. We cannot enrol beyond 20 days postrape 
because we assess mental health outcomes, such as 
PTSD, that are time sensitive to the traumatic event, as 
well as the assessment of HIV status at baseline, which is 
a key measurement.
We found that a larger proportion of patients reporting 
rape to the TCCs are children, which is different to the 
age profile statistics provided by NPA at the planning 
phase of the study. We used 2011–2013 NPA data to plan 
enrolment strategy. We also do not recruit mentally chal-
lenged rape survivors or those who are too emotional to 
discuss research participation.
Our initial recruitment process was dependent on the 
trained TCC staff’s ability to identify eligible participants, 
introduce the study, gain consent to be contacted by us 
(the researchers) and finally collect accurate contact 
details. The project staff then contacted the potential 
participant and invited them to our study clinic for formal 
consent procedures and the baseline interview (see 
figure 1). Although TCC staff were keen to assist us, our 
study was not their priority. We therefore enlisted the Life 
Line counselling staff, who provide the initial counselling 
service at the rape centres and we contribute towards their 
salary. However, when funding (United States Agency for 
International Development funding) for counselling 
services at the rape centres decreased at the end of 2015, 
the RICE investigators decided to employ dedicated RICE 
recruiters because recruitment remained low and it made 
financial sense to employ staff to increase the enrolment 
rather than to enrol over a longer period. We employed 
two of the Life Line counsellors to cover four recruitment 
sites. They set up the initial appointments and arrange 
the collection and transportation of the participants to 
our research clinic. Frequently, participants become 
non-contactable after agreeing to attend our research 
clinic for formal consent procedures, and this is a chal-
lenge. Participants provide incorrect contact numbers or 
our calls and voicemails remain unanswered. The latter 
often happens when final arrangements are being made 
or at time of transport pick-up. Such behaviour is also 
noted among the non-exposed group recruited at family 
planning clinics, and we suspect potential participants are 
reluctant to inform us directly that they do not want to 
participate in the research. They may feel socially coerced 
to agree but find a way to discontinue contact with us. 
We know that rape survivors’ lives are difficult postrape 
and they change their phone numbers (phones are some-
times lost/stolen at the time of the rape), or they relocate. 
We also know that their mental health status interferes in 
their ability to regain normality.13 52 This is an inherent 
challenge in our study, and staff are sensitive to rape survi-
vors and accept that this group of women may not want to 
participant in our study.
retention challenges and responses
Retaining participants in longitudinal studies is chal-
lenging, and rape survivors bring additional concerns. 
Indeed, abused women have been identified as among 
the ‘hard to reach’ populations in research, similar to 
drug users.38 Retention is also not often discussed in 
peer-reviewed journal articles, where study findings are 
the focus. We searched for lessons learnt from other 
studies but could not find longitudinal studies with large 
rape cohorts. Similarly, the HIV/AIDS sector has always 
grappled with retention in cohort studies.46 53 As indi-
cated above, we have participants who relocate to other 
provinces for safety reasons or as a coping strategy, or 
they find jobs in other towns. We are aware survivors 
experience a range of emotional difficulties with varying 
levels of distress and coping skills, and we know receiving 
support and care from others assist them on their road to 
recovery. We also know that there is poor integration of 
mental health within rape services, and although women 
can return to the rape centre, they often choose not to. 
Our study has a full-time qualified trauma counsellor 
who provides counselling support at the study clinic. 
Many, however, do not use this facility, and we may need 
to understand this better in follow-up studies. We find 
that women from both cohorts, who are counselled at 
our clinic, often seek assistance for their daily struggles. 
Women will report that their stresses are related to their 
difficult lives such as trying to find a job and securing 
income. Counselling sessions are often about assisting 
them to cope with these hardships. We expected more 
women to withdraw from the study because the research 
reminded them of the incident, but to date, among the 
26 women who withdrew at the time of writing this paper, 
only 2 mentioned this as the reason. There may be others 
who have withdrawn, but because this has not yet been 
communicated to us, we consider them loss to follow-up 
(LTFU).
We have activities beyond reimbursement to support 
retention. These include updating locator information at 
each visit, consent to use social media, maintaining tele-
phonic contacts between clinic visits, individual birthday 
wishes via WhatsApp, offering transport from the rape 
centre and a Saturday morning clinic to accommodate 
students and working women. We try to provide women 
with a pleasant experience at the clinic and offer mani-
cures and nail painting. We constantly explore other ways 
to improve their experience and are currently exploring 
offering 10–15 min head and neck massages. At the end 
of 2015, our retention rate was between 50% and 75% 
(depending on the visits), and we intensified our reten-
tion activities through an incremental increase in reim-
bursement monies for each additional visit, a present 
(necklace/bag/earrings) for those who attend their 
12-month and 24-month visit and an additional snack of 
a small chocolate or a packet of peanuts. We employed a 
retention counsellor whose primary task is to track and 
monitor participant attendance and to conduct prob-
lem-solving counselling of the retention barriers that 
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are identified. We also employed a driver for home visits, 
initially for once a week, which then increased this to 
twice a week. In January 2017, we employed two drivers. 
One was dedicated to conduct daily home visits to those 
who missed a visit, and the other was employed to trans-
port participants. However, home visits are not always 
successful. Sometimes, a home address is not found or 
the participant is not known by the household. This may 
be deliberate misinformation given to us as a form of 
avoidance. We also find cases where participants have left 
their rented homes and contact is completely lost. None-
theless, many home visits result in finding participants or 
getting updated telephone numbers.
We developed an early warning system of missed atten-
dance so that home visits are carried out soon after a 
missed appointment. These retention and tracking activ-
ities have become more complex because the number of 
baseline participants and follow-up visits increase. Each of 
our 2016 participants are expected to attend seven times 
(a total of 14 056 clinic visits). We started a monthly raffle 
where a grocery or pamper parcel worth R150.00 (US$10) 
can be won. Participants enter their study number into 
the visit box at each visit, and there is a draw at the end 
of each month.
Transport to the clinic remains one of the key chal-
lenges. We recruit women from a wide geographic area, 
and our study clinic within a regional hospital complex is 
only accessible by very unpredictable local taxi services. 
Participants report spending a long time travelling. Since 
the start of 2017, we have been offering all women trans-
port to the clinic, and participants are collected in the 
morning at their homes, the rape centre or a known 
agreed landmark (police station/taxi rank etc). Some 
women do not use the collection service because they 
profit slightly from the transport reimbursement and 
therefore prefer to use public transport. Transport coor-
dination requires very good communication among staff 
members and between the staff and participants. This 
is possible because almost all participants agree to use 
their personal phones to maintain contact with us and we 
commonly use Whatsapp—especially when arrangements 
are finalised after office hours.
lessons learnt and limitations
We have learnt many lessons on how to set up and manage 
a longitudinal study with rape victims, and we continue to 
learn as our study progresses. We do not expect enrol-
ment of rape-exposed participants to increase much 
beyond 26 per month because there are few other options 
left to increase recruitment from these four recruitment 
sites. Broadening the recruitment to other TCC sites is 
not financially feasible. We must accept that some women 
are not assertive enough to tell us that they do not want 
to participate in our study, and to avoid disapproval, they 
agree initially and thereafter evade contact. We must also 
be cognisant that power imbalances between researcher 
and participant may also be at play. More importantly, 
the postrape period is very difficult for survivors and they 
have to negotiate many unsympathetic environments, 
which may include the rape services (health, police, 
justice and social), unsupportive family and friends, as 
well as a broader social environment wherein rape stigma 
remains a reality.13 47
LTFU is the most common cause of attrition in cohort 
studies,46 and the loss of contact with the participants has 
caused frustration among staff. Continuous support and 
allowing staff to discuss their frustrations have enabled 
them to continue interacting sympathetically with trauma 
victims and to prevent vicarious trauma. The RICE study 
counsellor supports staff in addition to participants. We 
also ensure staff have access to an expert psychologist 
who spends a day with them every quarter to assist them 
in working with traumatised rape survivors. Staff have 
said they are encouraged when returning participants are 
clearly on a healing path (ie, they are less depressed or 
accept an HIV status and are starting ART), which makes 
the work a rewarding experience.
Difficulties in retention are well known in cohort 
studies, and we have learnt much in this regard. In 
hindsight, we should have employed the retention 
counsellor earlier in the study and should have placed 
greater effort on the home visit programme. We are 
continuously assessing and discussing how to improve 
retention, and we hope the two recent initiatives (trans-
port service and the raffle) will attract people to return. 
We may not be aware of all the factors influencing reten-
tion, and we hope the data from home visits and from 
our qualitative study will provide some insight to assist 
us in future longitudinal studies with sensitive partici-
pants. This study will also allow us to explore differen-
tial retention and LTFU between the two groups. Mental 
health may also influence retention of women who are 
depressed and/or anxious and/or using substances and 
are reluctant to attend the study clinic. The problem 
that women may struggle to attend care of any form 
after rape is well described in the literature on rape 
research because the attendance reminds them of the 
trauma.54 55 This will affect overall retention.
We are aware of the limitation of generalising the find-
ings to all rape survivors because low levels of reporting 
rape to the police are a well-known phenomenon locally 
and globally.15 56 Women who report a rape are likely 
to be different in several aspects from the wider group 
of women who experience rape and who do report it. 
Those who do report are more likely to have experi-
enced injuries, to have had witnesses or to have been 
raped by non-partners (strangers). However, these are 
also women who are accessible from the wider popula-
tion of women who are raped for longitudinal research 
on health outcomes. Women who come forward to 
the police or to health services are also the group 
who requires services and so is an important group to 
study. From a pragmatic point of view, the methodology 
employed here is justifiable, especially considering 
logistical difficulty and the high cost of recruiting a 
population-based cohort. Generalisability may also be 
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impacted on by the non-random, non-census nature of 
recruitment. Women may decline to participate in the 
study, and this could introduce bias, but we expect this 
to happen in both groups. We will aim to reduce this 
bias but will have to be cognisant that participation is by 
voluntary consent. It is also possible that some women 
who decline participation may do so because of pre-ex-
isting mental health problems. However, our control 
group is also women who attend health services and, in 
this way, the two groups are similar.
EthICs And dIssEMInAtIon
Ethical approval for the study was granted by the South 
African Medical Research Council’s (SAMRC) Ethics 
Committee. Rape is a key element of our study, and 
the safety of participants is paramount and guides the 
research process. Project staff receive extensive training 
on the ethics, safety and protection of participants. We 
use lessons learnt from previous studies of participants 
recruited at rape centres.47 48 We introduce the study to 
participants as a Women’s Health and Well-being Study to 
protect women from being identified as rape survivors. 
The study follows the WHO ethical and safety guidelines 
on conducting research on gender-based violence and 
applies good clinical practice.57 We also draw on guide-
lines developed for conducting intervention research 
on violence against women.58 We provide women with 
sufficient information as required by the SAMRC’s Ethics 
Committee on specific areas such as biometrics, children 
involvement (see below), genetic samples, HIV testing, 
hair samples and storage of blood. There is a separate 
consenting process for each of the above. We developed 
a brochure and information sheets for participants. 
Our previous experience highlighted the importance 
of providing full information, time to reflect and testing 
the understanding of consent before consent forms are 
signed. Participants are given a clear explanation of 
voluntariness of participation, and the option of with-
drawal is given at each visit.
Our study includes 16-year-old and 17-year-old girls who 
are recruited at one recruitment site (Crisis Centre). We 
did not receive approval from NPA to recruit those under 
18 years at the TCCs. For the children, we seek consent 
from both the parent/legal guardian and the child. It 
is important that the children we approach understand 
that their attendance at the rape centre to seek assistance 
will be revealed to the parent/legal guardian if disclo-
sure has not yet occurred. We are cognisant that some 
girls may not want their parent/guardians to know about 
the rape event, and we will not recruit girls if they are 
opposed to disclosure. The same applies to 16-year-old 
and 17-year-old children recruited at the family planning 
clinics. We consider 16 year olds to have sufficient matu-
rity and mental capacity to understand the study (this is 
acknowledged in the Children’s Act No. 38 of 2005 as 
amended by Act 41 of 2007), and the information sheet 
for them is the same as those for adult women. We only 
enrol a girl if both the parent/legal guardian and the 
child give consent to participate. We do not seek consent 
for HIV testing from the parent/legal guardian because 
according to South African law, parental consent is not 
required.
The research involves minimal risk to participants. 
However, questions may be intrusive and trigger emotions 
that can cause short-term psychological distress. All staff 
are trained to respond to any distress during the inter-
views and to provide containment. A trauma counsellor, 
employed at the start of the study, is available to provide 
support to participants and staff. Women who require 
further assistance are referred to appropriate services. 
NPA trained the staff on what may/may not be discussed 
with rape survivors to ensure the research does not 
compromise the legal process. To protect the project 
staff from having to testify in a trial and the integrity of 
the legal process, the questionnaire does not ask about 
circumstances of the rape until the rape case has been 
closed or the trial has commenced. We expect to have 
many cases closed either by the survivors or by the inves-
tigating team by the end of the follow-up period as shown 
in research on rape attrition in South Africa.59 We also do 
not have a concern for recall bias as such information on 
the outcome of the legal process is of great importance to 
most people.
We do not expect any major medical risks as part of 
the study. Participants may find the prospect of an HIV 
test distressing, but we anticipate that most participants 
would have been tested for HIV and would know their 
HIV status from the rape care received, from antenatal 
care or from family planning services. In addition, 
there have been major national HIV testing campaigns 
across the country.60 Our research nurses are trained to 
carry out HIV counselling and, together with the study 
trauma counsellor, can provide appropriate support 
and referral.
Project staff monitor adverse events at each visit. A 
serious adverse event is defined as experiencing violence 
by a partner due to participation in the study, or injury 
or hospitalisation due to the violence or death of a study 
participant for any reason. The research nurse moni-
tors and documents the occurrence of adverse events 
since the last study visit, at each visit. The nurse follows 
appropriate procedures for notification and responds 
to adverse events that arise. The number of events 
occurring in each cohort will be enumerated to deter-
mine whether there is a differential risk between study 
arms. The data manager will also monitor the adverse 
event data. Project staff are responsible for determining 
whether participation in the study is related to the 
adverse event or not, by exploring the circumstances 
surrounding the event. All events are reported to the 
SAMRC’s Ethics Committee.
All staff are trained on matters of confidentiality and this 
is maintained in the retention activities. Contacting partic-
ipants in the follow-up period poses a particular risk as 
identified in the guidelines for conducting gender-based 
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violence longitudinal studies,58 and we only recruit partic-
ipants who understand and agree on the follow-up nature 
of the study. At recruitment, we identify the different ways 
in which we can contact the participants (short message 
service, WhatsApp and home visits) and this is reviewed at 
each visit. All information is stored on secure computers 
or servers and protected by a firewall and passwords. Study 
data are kept separate from the forms that can link data 
to the participants (consent forms and retention forms). 
Participants are compensated with R80.00 (US$5.50) at 
the baseline interview with an incremental addition of 
R20 (US$1.30) at each follow-up visit. Participants are 
compensated for travel costs or transport is arranged if 
required. Participants are offered snacks, such as a sand-
wich and a cool drink, as well a choice of a small chocolate 
or a packet of nuts, during the visit to the research clinic.
Our study will generate an extensive set of results of 
interest to a wide audience. We will adopt a research 
uptake strategy that will involve policy makers, service 
providers, advocacy groups and academia, that is, peer-re-
viewed journal articles.
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